TITLE

Efficiency and Safety of Radioactive Iodine I-131 in Treatment of Thyroid Disease

AUTHOR(S)
Alimanovic-Alagic, Rubina; Kucukalic-Selimovic, Elma; Mekic, Mevludin
PUB. DATE
December 2009
SOURCE
Medicinski Arhiv;2009, Vol. 63 Issue 5, p299
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Thyroid gland is the largest endocrine gland in the body. The thyroid gland produces hormones that regulate the metabolism rate, affect the growth and many functions of various organ systems. Nuclear medicine technique is very useful diagnostic tool in detecting thyroid disease. Thyroid scintigraphy can reveal functional and anatomic information of thyroid gland. A variety of radiopharmaceuticals and methodologies have been used over the years in nuclear medicine. Iodine-131 has been used to image the thyroid several decades. Radioactive Iodine I-131 is useful for the treatment of hyperthyroidism and thyroid cancer. There were 100 participants included in the study who were treated with I-131. The participants were checked 6 months and 12 months after the beginning of the treatment. The results show normalization of the laboratory parameters and hormonal status at the control examinations after 6 months and 12 months therapy with I-131. The side effects did not appear in any of the patients, which demonstrates safe application.
ACCESSION #
47436255

 

Related Articles

  • Results of Rosiglitazone Therapy in Patients with Thyroglobulin-Positive and Radioiodine-Negative Advanced Differentiated Thyroid Cancer. Electron Kebebew; Sheila Lindsay; Orlo H. Clark; Kenneth A. Woeber; Randall Hawkins; Francis S. Greenspan // Thyroid;Sep2009, Vol. 19 Issue 9, p953 

    Background:Rosiglitazone is a peroxisome proliferator–activated receptor (PPAR) gamma agonist that has shown promise as both an antiproliferative and redifferentiating agent for the treatment of thyroid cancer in preclinical studies. We investigated the efficacy and side effects of...

  • BRAF mutation in papillary thyroid carcinoma. Xinying Li; Abdel-Mageed, Asim B.; Kandil, Emad // International Journal of Clinical & Experimental Medicine;2012, Vol. 5 Issue 4, p310 

    BRAF mutation is the most common genetic alternation in thyroid cancer, particularly in papillary thyroid cancer (PTC). Excessive activation of BRAF/MAPK signaling pathway due to BRAF mutation plays a central role in the tumorigenesis and development of PTC. The association of BRAF mutation with...

  • Hyperfunctioning Papillary Carcinoma Of Thyroid: A Case Report And Brief Literature Review. Sistla, Sarath Chandra; John, Jerry; Maroju, NandaKishore; Basu, Debdatta // Internet Journal of Endocrinology;2007, Vol. 3 Issue 3, p8 

    Hyperfunctioning thyroid carcinoma is a rare clinical condition. Coexisting carcinoma and hyperthyroidism implying a focus of malignancy in a hyperfunctioning thyroid gland is more common. Absence of hyperplastic thyroid tissue on histology in the former differentiates the two conditions. While...

  • Hyperfunctioning Papillary Carcinoma Of Thyroid: A Case Report And Brief Literature Review. Sistla, Sarath Chandra; John, Jerry; Maroju, NandaKishore; Basu, Debdatta // Internet Journal of Endocrinology;2007, Vol. 3 Issue 2, p4 

    Hyperfunctioning thyroid carcinoma is a rare clinical condition. Coexisting carcinoma and hyperthyroidism implying a focus of malignancy in a hyperfunctioning thyroid gland is more common. Absence of hyperplastic thyroid tissue on histology in the former differentiates the two conditions. While...

  • Clinical Trials for Progressive Differentiated Thyroid Cancer: Patient Selection, Study Design, and Recent Advances. Martin Schlumberger; Steven I. Sherman // Thyroid;Dec2009, Vol. 19 Issue 12, p1393 

    Treatment of metastatic differentiated thyroid cancer is first based on the use of radioiodine and thyrotropin-suppressive thyroid hormone treatment. The recent availability of molecular-targeted therapies has lead to reconsideration of the treatment strategy in differentiated thyroid cancer...

  • Reply. Sabri, O. // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 3, p394 

    Replies to a comment made on an article about the treatment of differentiated nonmedullary thyroid carcinoma. Effect of thyroid uptake of a second application of radioiodine; Results of a reduction in thyroid uptake; Difficulty in quantifying how much of the administered radioiodine is absorbed...

  • RADIOIODINE I-131 FOR THE THERAPY OF GRAVES' DISEASE. Mumtaz, Malik; Lim Shueh Lin; Khaw Chong Hui; Khir, Amir Sharifuddin Mohd // Malaysian Journal of Medical Sciences;Jan-Mar2009, Vol. 16 Issue 1, p25 

    Graves' disease is a common cause of hyperthyroidism. Treatment options for Graves' disease include antithyroid medication, surgery or radioactive iodine (I-131) or RAI. This review will focus on the approach to RAI therapy; discussing dose selection, patient preparation, and consideration...

  • Cardiovascular assessment of hyperthyroid patients with multinodular goiter before and after radioiodine treatment preceded by stimulation with recombinant human TSH. Maria Barca; Cesar Gruppi; Mucio Oliveira; Rossana Romão; Maria Cárdia; Ileana Rubio; Meyer Knobel; Geraldo Medeiros-Neto // Endocrine (1355008X);Oct2007, Vol. 32 Issue 2, p175 

    Abstract  Treatment of large multinodular goiter (MNG) with radioiodine preceded by recombinant human thyrotropin (0.1 mg rhTSH) has been shown to be a safe alternative for patients with comorbidities that preclude surgery. However, the increase in serum thyroid hormones that follows...

  • Power boost: Nuclear pharmacists essential to the Mass General patients care team. Erickson, Amy K. // Pharmacy Today;Feb2013, Vol. 19 Issue 2, following p76 

    The article offers information related to Allegra L. DePietro, Nuclear Pharmacy Manager at Massachusetts General Hospital. It mentions that DePietro is the one preparing adjunct imaging agents and radiopharmaceuticals used for nuclear medicine diagnostic scans. It cites that DePietro specializes...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics